Evaluation of Serum Proteome Sample Preparation Methods to Support Clinical Proteomics Applications

• Published in: Journal of the American Society for Mass Spectrometry Vol. 35; no. 11; pp. 2659 - 2669
• Main Authors: Twigg, Carly A. I., Perez, Jesenia M., Ryu, Joohyun, Hanson, Benjamin K., Barrera Estrada, Valerie J., Thomas, Stefani N.
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 06.11.2024
• Subjects: RapiGest SF; proteomics; iST-BCT; SMART Digest Trypsin; mass spectrometry; serum; biomarker
• ISSN: 1044-0305; 1879-1123; 1879-1123
• DOI: 10.1021/jasms.4c00131

Serum contains several proteins that are associated with disease-related processes. Mass spectrometry (MS)-based proteomics approaches greatly facilitate serum protein biomarker development. However, the serum proteome complexity presents a technical challenge for the accurate, sensitive, and reproducible quantification of proteins by MS. Thus, efficient sample preparation methods are of critical importance for serum proteome analyses. In this study, we evaluated the technical performance of two serum proteome sample preparation methods using sera from patients with high-grade serous ovarian cancer and patients with benign nongynecological conditions with a goal of providing insight into their compatibility with clinical proteomics workflows. One method entailed the use of immobilized trypsin (SMART Digest Trypsin) with RapiGest SF, an acid-labile surfactant designed to enhance the in-solution enzymatic digestion of proteins. The other method incorporated a commercially available sample preparation kit, iST-BCT, which contains standardized reagents. Significantly higher protein sequence coverage, albeit with lower digestion efficiency, was obtained with the immobilized trypsin + RapiGest SF workflow, whereas the iST-BCT workflow was quicker and had marginally better reproducibility. Protein relative abundance analysis revealed that the serum proteomes clustered primarily by the sample processing workflow and secondarily by disease state. We conducted a time course study to determine whether differences in the relative abundance of diagnostic high-grade serous ovarian cancer serum protein biomarker candidates were biased according to the duration of enzymatic digestion. Our results highlight the importance of optimizing enzymatic digestion kinetics according to the peptide targets of interest while considering the sensitivity of the downstream analytical method utilized in clinical proteomics workflows designed to measure biomarkers.